title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - JanOne  ( NASDAQ:JAN ) ,20240513T094610,https://www.benzinga.com/news/24/05/38783309/why-janone-shares-are-trading-higher-by-19-here-are-20-stocks-moving-premarket,SNY,0.067536,Somewhat-Bullish,0.200818
"Earnings Scheduled For April 28, 2022",20220428T085040,https://www.benzinga.com/news/earnings/22/04/26860440/earnings-scheduled-for-april-28-2022,SNY,0.014477,Neutral,-0.001809
"Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight",20240409T214100,https://www.prnewswire.com/news-releases/global-tissue-banking-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2030-assesses-delveinsight-302110459.html,SNY,0.022991,Neutral,0.037011
"Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure",20240711T131200,https://www.zacks.com/stock/news/2300042/biotech-stock-roundup-kymr-idya-qure-soar-on-study-data-hlvx-tanks-on-study-failure,SNY,0.156207,Somewhat-Bullish,0.15601
"Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback",20231012T122400,https://www.zacks.com/stock/news/2164807/biotech-stock-roundup-bmy-grabs-mrtx-akro-down-on-study-data-alny-faces-setback,SNY,0.033751,Neutral,0.032519
"Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit - Cisco Systems  ( NASDAQ:CSCO ) , Darden Restaurants  ( NYSE:DRI ) ",20230921T183004,https://www.benzinga.com/news/earnings/23/09/34803375/dow-tumbles-200-points-darden-restaurants-posts-upbeat-profit,SNY,0.107255,Neutral,0.129334
"Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected - MSP Recovery  ( NASDAQ:LIFW ) , Neptune Wellness Solns  ( NASDAQ:NEPT ) ",20230921T135921,https://www.benzinga.com/news/earnings/23/09/34793343/nasdaq-down-over-1-us-initial-jobless-claims-fall-more-than-expected,SNY,0.124809,Neutral,0.137247
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive ... - PR Newswire,20231201T183000,https://www.prnewswire.com/news-releases/neuromuscular-disease-therapeutics-market-size-to-grow-by-usd-65-13-billion-from-2022-2027-aquestive-therapeutics-inc-bausch-health-companies-inc-biogen-inc-and-more-among-the-major-companies-in-the-market--technavio-302002042.html,SNY,0.059636,Neutral,0.014995
"DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors - DBV Technologies  ( NASDAQ:DBVT ) , Aquestive Therapeutics  ( NASDAQ:AQST ) ",20221003T203000,https://www.benzinga.com/pressreleases/22/10/g29126135/dbv-technologies-announces-appointment-of-new-chair-of-its-audit-committee-and-appointment-of-dani,SNY,0.038284,Neutral,0.047891
DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors,20221003T203000,https://www.globenewswire.com/news-release/2022/10/03/2527329/0/en/DBV-Technologies-Announces-Appointment-of-New-Chair-of-its-Audit-Committee-and-Appointment-of-Daniele-Guyot-Caparros-to-Board-of-Directors.html,SNY,0.033656,Neutral,0.047894
Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period  ( 2019-2032 )  | DelveInsight,20231121T220100,https://www.prnewswire.com/news-releases/colorectal-cancer-treatment-drug-market-to-show-immense-growth-during-the-study-period-20192032--delveinsight-301994315.html,SNY,0.046184,Neutral,-0.032778
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,SNY,0.02074,Neutral,-0.020974
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket,20220817T100654,https://www.benzinga.com/news/22/08/28530257/why-hill-international-shares-are-trading-higher-by-58-here-are-25-stocks-moving-premarket,SNY,0.091509,Neutral,-0.141686
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",20231214T221500,https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,SNY,0.078099,Neutral,0.0
MacroGenics  ( MGNX )  Q3 2024 Earnings Call Transcript,20241106T031514,https://www.fool.com/earnings/call-transcripts/2024/11/05/macrogenics-mgnx-q3-2024-earnings-call-transcript/,SNY,0.008183,Neutral,0.100133
Crude Oil Down 1%; Sweetgreen Shares Spike Higher - Macrogenics  ( NASDAQ:MGNX ) ,20240510T183023,https://www.benzinga.com/news/24/05/38768201/crude-oil-down-1-sweetgreen-shares-spike-higher,SNY,0.077094,Somewhat-Bullish,0.174502
Nasdaq Moves Lower; US Consumer Sentiment Falls In May - Novavax  ( NASDAQ:NVAX ) ,20240510T162224,https://www.benzinga.com/news/earnings/24/05/38765474/nasdaq-moves-lower-us-consumer-sentiment-falls-in-may,SNY,0.081276,Somewhat-Bullish,0.175689
"Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings - Dnow  ( NYSE:DNOW ) , Evolv Technologies  ( NASDAQ:EVLV ) ",20240510T140059,https://www.benzinga.com/news/24/05/38761518/dow-jumps-over-100-points-dnow-posts-downbeat-earnings,SNY,0.075874,Somewhat-Bullish,0.174196
MacroGenics  ( MGNX )  Q4 2023 Earnings Call Transcript,20240308T053017,https://www.fool.com/earnings/call-transcripts/2024/03/08/macrogenics-mgnx-q4-2023-earnings-call-transcript/,SNY,0.012228,Neutral,0.081069
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results,20240228T220000,https://www.newswire.ca/news-releases/dri-healthcare-trust-reports-fourth-quarter-and-fiscal-2023-results-808176485.html,SNY,0.008908,Somewhat-Bullish,0.164782
MacroGenics  ( MGNX )  Q3 2023 Earnings Call Transcript,20231107T061542,https://www.fool.com/earnings/call-transcripts/2023/11/07/macrogenics-mgnx-q3-2023-earnings-call-transcript/,SNY,0.014595,Neutral,0.094169
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",20230918T091500,https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,SNY,0.043108,Neutral,0.0
3 Under-the-Radar Biotech Stocks to Buy in 2023,20230819T114000,https://www.fool.com/investing/2023/08/19/3-under-the-radar-biotech-stocks-to-buy-in-2023/,SNY,0.097259,Neutral,0.013139
MacroGenics'  ( MGNX )  Shares Jump 19% in One Week: Here's Why,20230814T151900,https://www.zacks.com/stock/news/2136295/macrogenics-mgnx-shares-jump-19-in-one-week-heres-why,SNY,0.374714,Somewhat-Bullish,0.184453
Why Shares of MacroGenics Are Jumping Thursday,20230810T163341,https://www.fool.com/investing/2023/08/10/why-shares-of-macrogenics-are-jumping-thursday/,SNY,0.459624,Neutral,0.10264
MacroGenics  ( MGNX )  Q2 2023 Earnings Call Transcript,20230810T033023,https://www.fool.com/earnings/call-transcripts/2023/08/09/macrogenics-mgnx-q2-2023-earnings-call-transcript/,SNY,0.036277,Neutral,0.10025
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results - Macrogenics  ( NASDAQ:MGNX ) ,20230809T200100,https://www.benzinga.com/pressreleases/23/08/g33677875/macrogenics-provides-update-on-corporate-progress-and-second-quarter-2023-financial-results,SNY,0.183372,Somewhat-Bullish,0.176532
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain,20230626T210100,https://www.prnewswire.com/news-releases/antibody-drug-conjugates-clinical-trial-pipeline-experiences-momentum-delveinsight-estimates-a-diverse-pipeline-comprising-180-companies-working-in-the-domain-301862784.html,SNY,0.083468,Neutral,-0.023781
Here's Why You Should Add ImmunoGen  ( IMGN )  to Your Portfolio Now,20230519T150900,https://www.zacks.com/stock/news/2097447/heres-why-you-should-add-immunogen-imgn-to-your-portfolio-now,SNY,0.073098,Neutral,0.138138
MacroGenics  ( MGNX )  Q1 2023 Earnings Call Transcript,20230510T043040,https://www.fool.com/earnings/call-transcripts/2023/05/10/macrogenics-mgnx-q1-2023-earnings-call-transcript/,SNY,0.028277,Neutral,0.099957
MacroGenics  ( MGNX )  Q4 2022 Earnings Call Transcript,20230316T030035,https://www.fool.com/earnings/call-transcripts/2023/03/15/macrogenics-mgnx-q4-2022-earnings-call-transcript/,SNY,0.0379,Somewhat-Bullish,0.159208
Provention  ( PRVB )  Skyrockets 260% on Buyout Offer From Sanofi,20230314T163200,https://www.zacks.com/stock/news/2065615/provention-prvb-skyrockets-260-on-buyout-offer-from-sanofi,SNY,0.724016,Somewhat-Bullish,0.220782
"Illumina, Seagen And Other Big Stocks Moving Higher On Monday - Agenus  ( NASDAQ:AGEN ) , First Majestic Silver  ( NYSE:AG ) ",20230313T145550,https://www.benzinga.com/news/23/03/31322709/illumina-seagen-and-other-big-stocks-moving-higher-on-monday,SNY,0.08183,Somewhat-Bullish,0.287233
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELDâ„¢  ( teplizumab-mzwv )  and Updates Long-Term Cash Receipts Outlook,20230308T223000,https://www.newswire.ca/news-releases/dri-healthcare-trust-announces-acquisition-of-a-royalty-interest-in-the-worldwide-sales-of-tzield-tm-teplizumab-mzwv-and-updates-long-term-cash-receipts-outlook-870382808.html,SNY,0.030408,Neutral,0.060126
Provention  ( PRVB )  Gets FDA Nod for Drug That Delays T1D Onset,20221118T151500,https://www.zacks.com/stock/news/2019947/provention-prvb-gets-fda-nod-for-drug-that-delays-t1d-onset,SNY,0.444919,Bullish,0.543637
Why Provention Bio  ( PRVB )  Shares Are Trading Higher Premarket Today? - Provention Bio  ( NASDAQ:PRVB ) ,20221118T113942,https://www.benzinga.com/general/biotech/22/11/29780945/first-drug-that-can-delay-onset-of-type-1-diabetes-gets-fda-approval-after-multiple-regulatory-hu,SNY,0.268294,Neutral,0.055124
U.S. FDA greenlights Provention Bio's diabetes drug,20221117T233200,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-greenlights-provention-bios-diabetes-drug-2022-11-17/,SNY,0.34729,Somewhat-Bullish,0.162723
Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update,20221103T110000,https://www.prnewswire.com/news-releases/provention-bio-reports-third-quarter-2022-financial-results-and-provides-business-update-301667012.html,SNY,0.156461,Somewhat-Bullish,0.164696
"The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death",20220711T125503,https://www.benzinga.com/general/biotech/22/07/28015717/the-daily-biotech-pulse-europe-approves-second-round-of-booster-doses-of-mrna-covid-19-vaccines-p,SNY,0.236396,Somewhat-Bearish,-0.172528
